Cell Line
BT-474; BT474; Bt-474; BT474
Organism
human (Homo sapiens)
Tissue/Cell type
breast ductal carcinoma
Genetically modified (GenTSV)
Risk group (BioStoffV), sensitizing or toxic effects
1
Risk assessment
According to ZKBS (https://zag.bvl.bund.de/zelllinien/detail.jsf?dswid=5982&dsrid=204&id=651)
Storage location of aliquots in the Biolab (just click Bearbeiten in the right corner of the header to add or change information in the table and use the menue in the left header to e.g. add a row)
| source | freezing date | passage no. | cell count per vial | cell culture medium incl. supplements | no. of aliquots | belongs to (full name) | rack/box in N2 tank or -80°C freezer and location (room, address) | comments |
|---|---|---|---|---|---|---|---|---|
| Charité, Chuanbing Zhang/Jan Eucker | 24.06.2021 | px+1 | 500000 | RPMI+10%FBS | 4 | Katharina Achazi (Peng Tang) | 02/07, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) | |
| DSMZ | 17.07.2023 | 80% RPMI 1640 + 20% h.i. FBS + 10 µg/ml human insulin + 2 mM L-glutamine | 1 | Britt Schaffranietz | 01/04/08, N2 tank (SupraFab, Altensteinstraße 23a, 114.1) |
